Skip to main content
. 2020 Jan 9;105(4):e1847–e1861. doi: 10.1210/clinem/dgz310

Table 4.

Statistical analysis of height SDS change from baseline

ETD (95% CI)
Wk 26 Wk 52
Somapacitan 0.16 mg/kg/wk—daily GH 0.16 (–0.06 to 0.38) 0.35 (0.05 to 0.65)
Somapacitan 0.08 mg/kg/wk—daily GH –0.08 (–0.30 to 0.14) –0.10 (–0.39 to 0.20)
Somapacitan 0.04 mg/kg/wk—daily GH –0.44 (–0.66 to –0.22) –0.58 (–0.88 to –0.28)

Abbreviations: ETD, estimated treatment difference; GH, growth hormone; SDS, SD score; wk, week.